Peripheral Arterial Disease

A comprehensive, quick-reference guide to the diagnosis and management of peripheral artery disease for non-specialists With an aging population subject to an increasing number of health risks, peripheral artery disease (PAD) is on the rise throughout the world. Because of PAD's direct links to heart attack and stroke, it is critical that internists, surgeons, cardiologists, radiologists, gerontologists, GPs, and family practitioners know how to recognize it and make the best treatment recommendations for their patients. This book provides all the expert, practical information and guidance they need to do just that. Edited by two thought leaders in PAD diagnosis and treatment, and comprising chapters written by subject matter experts, Peripheral Artery Disease, Second Edition provides clinicians with guidance on how to diagnose and treat one of the most under-diagnosed conditions affecting millions of patients. This updated and revised edition of the popular guide distills the complexities of PAD into clear, actionable advice for busy medical practitioners, providing them with the information they need—when they need it. Provides clinicians with essential information for recognizing and treating this under-diagnosed condition that affects millions of patients Distills the complexities of PAD, from diagnosis to traditional and emerging treatment options, into clear, actionable advice for clinicians Covers PAD epidemiology, office examination, imaging, laboratory evaluation, medical therapy, surgical interventions, endovascular treatments, and much more Reflects the latest PAD Guidelines and Performance Measures established by leading specialty societies Features contributions from internists and surgeons, all recognized experts in PAD Peripheral Artery Disease, Second Edition is an important working reference for internists, cardiologists, radiologists, and surgeons, as well as fellows and residents in those fields.

The Social Security Administration (SSA) uses a screening tool called the Listing of Impairments to identify claimants who are so severely impaired that they cannot work at all and thus immediately qualify for benefits. In this report, the IOM makes several recommendations for improving SSA's capacity to determine disability benefits more quickly and efficiently using the Listings.

Cardiovascular, respiratory, and related conditions cause more than 40 percent of all deaths globally, and their substantial burden is rising, particularly in low- and middle-income countries (LMICs). Their burden extends well beyond health effects to include significant economic and societal consequences. Most of these conditions are related, share risk factors, and have common control measures at the clinical, population, and policy levels. Lives can be extended and improved when these diseases are prevented, detected, and managed. This volume summarizes current knowledge and presents evidence-based interventions that are effective, cost-effective, and scalable in LMICs.

Approximately eight to twelve million individuals in the United States are affected by peripheral arterial disease (PAD). With 200 tables and illustrations and a single focus on peripheral arterial disease (PAD) rather than all vascular disorders, this Handbook is the ultimate clinical care primer for those who seek the most up-to-date and practical PAD clinical strategies. Comprehensive and easy-to-use, the book presents epidemiological and pathophysiological data in succinct format and includes a unique compendium of evidenced-based and expert approaches for the diagnosis and treatment of peripheral arterial diseases. The diagnostic and treatment algorithms are derived from the experience of national experts, and should provide guidance to both trainees and practicing clinicians.

Market: Cardiologists, Vascular Specialists, Vascular Surgeons, Hematologists, Internists, Family Physicians, Rheumatologists More than 500 color charts and tables Includesw an entire section on diagnostic imaging modalities

​This book presents up-to-date information on clinical and research applications of imaging in peripheral arterial disease (PAD). It provides high-quality images useful not only in the diagnosis of PAD but also for use in clinical trials aimed at the development of novel therapies such as angiogenic agents and stem cells. The book begins with coverage of the applications of the four major imaging modalities in a clinical setting: ultrasound, computed tomography angiography (CTA), magnetic resonance angiography (MRA), and digital subtraction angiography (DSA). It also discusses the ankle brachial index (ABI) as a screening technique to establish the presence of PAD. Subsequent chapters focus on the advantages and limitations of various research applications of imaging in PAD including contrast ultrasound for measuring perfusion; MRI for assessing perfusion, energetics, plaque volume, and characteristics; and radionuclide imaging for perfusion and inflammation. Imaging in Peripheral Arterial Disease: Clinical and Research Applications is an essential resource for physicians, researchers, residents, and fellows in cardiology, radiology, imaging, nuclear medicine, diagnostic radiology, and vascular surgery.

A comprehensive review the state-of-the-art in atherosclerosis of the arteries of the legs and feet. The authors discuss in detail the primary symptom-claudication-an intermittent pain in the leg or foot while walking, its predisposing factors, the current diagnostic methodologies, the impressive advances in the therapeutic armamentarium, and the need to screen for co-existing coronary artery disease. Additional chapters describe cutting-edge noninvasive angiography and vascular flow studies, specific drug therapy for claudication, regression of atherosclerosis therapy, gene therapy, and drug eluting stents for peripheral arterial disease. The authors also examine the epidemiology of LEAD, the effects of smoking and effective smoking cessation programs, its pathogenesis and its association with lipid abnormalities and hypertension, aggressive risk factor modification, and the need to measure the ankle brachial index of every patient over 45.